scispace - formally typeset
Open AccessJournal ArticleDOI

Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis

Reads0
Chats0
TLDR
Reductions in BP with NHD are accompanied by regression of LVH, and there was no relationship between changes in LVMI and changes in BP or Hb in the CHD cohort.
About
This article is published in Kidney International.The article was published on 2002-06-01 and is currently open access. It has received 360 citations till now. The article focuses on the topics: Left ventricular hypertrophy & End stage renal disease.

read more

Citations
More filters
Journal ArticleDOI

Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference.

TL;DR: This report summarizes the deliberations and recommendations of a conference sponsored by the Kidney Disease: Improving Global Outcomes (KDIGO) to address the following questions: what is the optimal BP treatment target in relation to end-organ damage and outcomes in dialysis patients; how should antihypertensive drugs be used in dial renal patients; and what nonpharmacological therapies can be considered in achieving BP targets.
Journal ArticleDOI

High-performance silicon nanopore hemofiltration membranes

TL;DR: This is the first report of successful prolonged hemofiltration with a silicon nanopore membrane, and demonstrates feasibility of renal replacement devices based on these membranes and materials.
Journal ArticleDOI

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure.

TL;DR: In this article, the authors suggest that high-level exposure to traditional risk factors, such as smoking and dyslipidemia, hemodynamic overload factors such as anemia and hypertension, and a myriad of metabolic factors related to uremia are all likely to play a role.
Journal ArticleDOI

Improvement in ejection fraction by nocturnal haemodialysis in end‐stage renal failure patients with coexisting heart failure

TL;DR: In ESRD patients with systolic dysfunction, NHD leads to a sustained increase of EF and a reduction in the requirement for vasoactive medications in the absence of any reduction in post-dialysis ECFV.
References
More filters
Journal ArticleDOI

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Richard B. Devereux, +1 more
- 01 Apr 1977 - 
TL;DR: The best method for LVM-E identified combined cube function geometry with a modified convention for determination of left ventricular internal dimension (LVID), posterior wall thickness (PWT), and interventricular septal thickness (IVST), which excluded the thickness of endocardial echo lines from wall thicknesses and included the thickness in LVID.
Journal ArticleDOI

Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension

TL;DR: Correspondence of left ventricular mass in concentric remodeling appeared to reflect offsetting by volume "underload" of the effects of pressure overload, whereas eccentric hypertrophy was associated with concomitant pressure and volume overload.
Journal ArticleDOI

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

TL;DR: It is concluded that clinical and echocardiographic cardiovascular disease are already present in a very high proportion of patients starting ESRD therapy and are independent mortality factors.
Journal ArticleDOI

Echocardiographic criteria for left ventricular hypertrophy: the Framingham heart study

TL;DR: Until outcome guided criteria for LV hypertrophy are developed, application of sex-specific criteria based on a healthy population distribution of LV mass offer the best approach to echocardiographic diagnosis of LVhypertrophy.
Journal ArticleDOI

Impact of left ventricular hypertrophy on survival in end-stage renal disease.

TL;DR: Left ventricular hypertrophy appears to be an important, independent, determinant of survival in patients receiving therapy for end-stage renal failure in patients beginning renal replacement therapy.
Related Papers (5)